Analyst Ratings for Cara Therapeutics (CARA) [Neutrals]
CARA Rating Summary
CARA Price Target Summary
- Highest: $25.00 (Stifel)
- Lowest: $1.00 (Piper Sandler)
- Average: $12.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.17 (+1589.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$12.17 (+1589.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2023 | Piper Sandler | David Amsellem | Downgrade | Neutral (Overweight) |
1.00 (12.00) |
1.05 (0.72) |
-31.43% | Details |
